Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Sigma Lithium
SGML
$1.24B
| $1.39M | ﹤0.01% |
36,986
+12,760
| +53% | +$409K |
|
|
SGI
2427
Somnigroup International
SGI
$14.6B
| $1.39M | ﹤0.01% |
35,234
-534,042
| -94% | -$21.2M |
|
2428
Pacira BioSciences
PCRX
$1.07B
| $1.39M | ﹤0.01% |
34,089
+6,671
| +24% | +$265K |
|
|
TGVC
2429
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
| $1.39M | ﹤0.01% |
133,904
| – | – |
|
2430
Benchmark Electronics
BHE
$3.08B
| $1.39M | ﹤0.01% |
58,618
+8,619
| +17% | +$218K |
|
2431
Univest Financial
UVSP
$1.24B
| $1.39M | ﹤0.01% |
58,426
+17,414
| +42% | +$461K |
|
2432
Washington Trust Bancorp
WASH
$760M
| $1.39M | ﹤0.01% |
39,994
+20,159
| +102% | +$850K |
|
2433
Westamerica Bancorp
WABC
$1.39B
| $1.38M | ﹤0.01% |
31,233
+12,971
| +71% | +$698K |
|
|
PGTI
2434
DELISTED
PGT, Inc.
PGTI
| $1.38M | ﹤0.01% |
55,084
-6,822
| -11% | -$145K |
|
2435
Provident Financial Services
PFS
$3.29B
| $1.38M | ﹤0.01% |
72,106
+36,278
| +101% | +$803K |
|
|
PLL
2436
PUT
DELISTED
Piedmont Lithium
PLL
| $1.38M | ﹤0.01% |
+23,000
| New | +$1.4M |
|
|
ARNC
2437
DELISTED
Arconic Corporation
ARNC
| $1.38M | ﹤0.01% |
52,559
-50,728
| -49% | -$1.25M |
|
|
VGR
2438
DELISTED
Vector Group Ltd.
VGR
| $1.38M | ﹤0.01% |
114,754
+47,845
| +72% | +$603K |
|
2439
HSBC
HSBC
$363B
| $1.38M | ﹤0.01% |
40,357
-1,995
| -5% | -$71.6K |
|
|
EVA
2440
PUT
DELISTED
Enviva Inc.
EVA
| $1.37M | ﹤0.01% |
47,600
-8,200
| -15% | -$335K |
|
2441
AMC Entertainment Holdings
AMC
$2.44B
| $1.37M | ﹤0.01% |
27,419
-4,059
| -13% | -$215K |
|
2442
Sterling Infrastructure
STRL
$16.5B
| $1.37M | ﹤0.01% |
36,253
+14,218
| +65% | +$519K |
|
|
SEM
2443
DELISTED
Select Medical
SEM
| $1.37M | ﹤0.01% |
98,585
-11,533
| -10% | -$170K |
|
2444
Resideo Technologies
REZI
$3.95B
| $1.37M | ﹤0.01% |
75,002
+4,794
| +7% | +$86.7K |
|
2445
Hydrofarm Holdings
HYFM
$8.86M
| $1.37M | ﹤0.01% |
79,233
+78,061
| +6,660% | +$1.38M |
|
2446
Target Hospitality
TH
$1.59B
| $1.37M | ﹤0.01% |
103,960
+72,110
| +226% | +$1.15M |
|
2447
Gentex
GNTX
$5.13B
| $1.37M | ﹤0.01% |
48,730
+16,637
| +52% | +$469K |
|
2448
uniQure
QURE
$3.03B
| $1.36M | ﹤0.01% |
67,485
-39,560
| -37% | -$830K |
|
|
AXNX
2449
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.36M | ﹤0.01% |
24,890
+3,767
| +18% | +$220K |
|
2450
Herbalife
HLF
$1.33B
| $1.36M | ﹤0.01% |
84,305
+18,121
| +27% | +$320K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.